Document is current
Any future updates will be listed below
-
Authors
Rujas, Edurne
Kucharska, Iga
Tan, Yong Zi http://orcid.org/0000-0001-6656-6320
Benlekbir, Samir
Cui, Hong
Zhao, Tiantian
Wasney, Gregory A.
Budylowski, Patrick
Guvenc, Furkan
Newton, Jocelyn C.
Sicard, Taylor
Semesi, Anthony
Muthuraman, Krithika
Nouanesengsy, Amy
Aschner, Clare Burn http://orcid.org/0000-0001-8940-5423
Prieto, Katherine
Bueler, Stephanie A.
Youssef, Sawsan
Liao-Chan, Sindy
Glanville, Jacob
Christie-Holmes, Natasha
Mubareka, Samira
Gray-Owen, Scott D. http://orcid.org/0000-0002-1477-3616
Rubinstein, John L. http://orcid.org/0000-0003-0566-2209
Treanor, Bebhinn http://orcid.org/0000-0002-8626-5944
Julien, Jean-Philippe http://orcid.org/0000-0001-7602-3995
- License Information
-
More Information
Article History
Received: 13 January 2021
Accepted: 19 May 2021
First Online: 16 June 2021
Competing interests
: The Hospital for Sick Children has applied for patents concerning SARS-CoV-2 antibodies and the Multabody platform technology that are related to this work. B.T. and J.-P.J. are founders of Radiant Biotherapeutics and are members of its Scientific Advisory Board. S.Y., S.L.C., and J.G. are employees of DistributedBio and may hold shares in DistributedBio. The remaining authors declare no competing interests.
